Gilot D[au] - Search Results

Year	Number of Results
2000	1
2001	1
2002	5
2003	5
2004	1
2005	3
2006	3
2007	2
2008	3
2009	1
2010	2
2011	2
2013	1
2014	3
2015	1
2016	2
2017	4
2018	3
2020	3
2021	8
2022	6

1

Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies.

Leclerc D, Staats Pires AC, Guillemin GJ, Gilot D. Leclerc D, et al. Among authors: gilot d. Curr Opin Immunol. 2021 Jun;70:15-26. doi: 10.1016/j.coi.2020.12.003. Epub 2021 Jan 8. Curr Opin Immunol. 2021. PMID: 33429228 Free article. Review.

2

Human TYRP1: Two functions for a single gene?

Gautron A, Migault M, Bachelot L, Corre S, Galibert MD, Gilot D. Gautron A, et al. Among authors: gilot d. Pigment Cell Melanoma Res. 2021 Sep;34(5):836-852. doi: 10.1111/pcmr.12951. Epub 2021 Feb 16. Pigment Cell Melanoma Res. 2021. PMID: 33305505 Free article. Review.

3

Involvement of Kynurenine Pathway in Hepatocellular Carcinoma.

Krishnamurthy S, Gilot D, Ahn SB, Lam V, Shin JS, Guillemin GJ, Heng B. Krishnamurthy S, et al. Among authors: gilot d. Cancers (Basel). 2021 Oct 15;13(20):5180. doi: 10.3390/cancers13205180. Cancers (Basel). 2021. PMID: 34680327 Free PMC article. Review.

4

The powerful world of antisense oligonucleotides: From bench to bedside.

Quemener AM, Bachelot L, Forestier A, Donnou-Fournet E, Gilot D, Galibert MD. Quemener AM, et al. Among authors: gilot d. Wiley Interdiscip Rev RNA. 2020 Sep;11(5):e1594. doi: 10.1002/wrna.1594. Epub 2020 Mar 31. Wiley Interdiscip Rev RNA. 2020. PMID: 32233021 Review.

5

Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective.

Amendola M, Bedel A, Buj-Bello A, Carrara M, Concordet JP, Frati G, Gilot D, Giovannangeli C, Gutierrez-Guerrero A, Laurent M, Miccio A, Moreau-Gaudry F, Sourd C, Valton J, Verhoeyen E. Amendola M, et al. Among authors: gilot d. Hum Gene Ther. 2021 Oct;32(19-20):1059-1075. doi: 10.1089/hum.2021.191. Hum Gene Ther. 2021. PMID: 34494480 Review.

6

CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and resistance.

Gautron A, Bachelot L, Aubry M, Leclerc D, Quéméner AM, Corre S, Rambow F, Paris A, Tardif N, Leclair HM, Marin-Bejar O, Coulouarn C, Marine JC, Galibert MD, Gilot D. Gautron A, et al. Among authors: gilot d. EMBO Mol Med. 2021 May 7;13(5):e13466. doi: 10.15252/emmm.202013466. Epub 2021 Mar 16. EMBO Mol Med. 2021. PMID: 33724679 Free PMC article.

7

PTPN11 mutations in canine and human disseminated histiocytic sarcoma.

Hédan B, Rault M, Abadie J, Ulvé R, Botherel N, Devauchelle P, Copie-Bergman C, Cadieu E, Parrens M, Alten J, Zalcman EL, Cario G, Damaj G, Mokhtari K, Le Loarer F, Coulomb-Lhermine A, Derrien T, Hitte C, Bachelot L, Breen M, Gilot D, Blay JY, Donadieu J, André C. Hédan B, et al. Among authors: gilot d. Int J Cancer. 2020 Sep 15;147(6):1657-1665. doi: 10.1002/ijc.32991. Epub 2020 Apr 8. Int J Cancer. 2020. PMID: 32212266 Free article.

8

Definition and identification of small RNA sponges: Focus on miRNA sequestration.

Migault M, Donnou-Fournet E, Galibert MD, Gilot D. Migault M, et al. Among authors: gilot d. Methods. 2017 Mar 15;117:35-47. doi: 10.1016/j.ymeth.2016.11.012. Epub 2016 Nov 19. Methods. 2017. PMID: 27876678 Free article. Review.

9

miRNA displacement as a promising approach for cancer therapy.

Gilot D, Galibert MD. Gilot D, et al. Mol Cell Oncol. 2017 Dec 11;5(1):e1406432. doi: 10.1080/23723556.2017.1406432. eCollection 2018. Mol Cell Oncol. 2017. PMID: 29404400 Free PMC article.

10

Modulation of Bacterial sRNAs Activity by Epigenetic Modifications: Inputs from the Eukaryotic miRNAs.

Felden B, Gilot D. Felden B, et al. Among authors: gilot d. Genes (Basel). 2018 Dec 31;10(1):22. doi: 10.3390/genes10010022. Genes (Basel). 2018. PMID: 30602712 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results